PXD055918 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Apolipoprotein A-IV is induced by high-fat diets and mediates positive effects on glucose and lipid metabolism |
Description | Low-carbohydrate, high-fat diets under eucaloric conditions are associated with several health-beneficial metabolic effects in humans, particularly in the liver. We recently observed that apolipoprotein A-IV (apoA-IV), a highly abundant apolipoprotein, was among the most upregulated proteins in the circulation after six weeks of high fat intake in humans. However, the dietary regulation of apoA-IV and the potential effects of apoA-IV on regulation of glucose- and lipid metabolism remain to be fully established. We here demonstrate in healthy human individuals that both short- and long-term high-fat intake increased fasting plasma apoA-IV concentrations by up to 54%, while high carbohydrate intake suppressed plasma apoA-IV concentrations. In mice, administration of apoA-IV acutely lowered blood glucose levels in lean and obese mice. Interestingly, this was related to a dual mechanism, involving both inhibition of hepatic glucose production and increased glucose uptake into white and brown adipose tissues. In addition to an effect on hepatic glucose production, the apoA-IV-induced liver proteome revealed increased capacity for lipoprotein clearance. The effects of apoA-IV in the liver and adipose tissues were obtained concomitant with increased whole-body fatty acid oxidation. Upon glucose stimulation, an improvement in glucose tolerance by apoA-IV administration was related to potentiation of glucose-induced insulin secretion, while apoA-IV inhibited glucagon secretion ex vivo in islets. In conclusion, we find that ApoA-IV is potently increased by the intake of fat in humans, and that several beneficial metabolic effects, previously associated with high fat intake in humans, are mimicked by administration of apoA-IV protein to mice. |
HostingRepository | PRIDE |
AnnounceDate | 2025-05-07 |
AnnouncementXML | Submission_2025-05-07_02:56:24.641.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Mark Larance |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
ModificationList | acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-09-16 15:29:54 | ID requested | |
⏵ 1 | 2025-05-07 02:56:25 | announced | |
Publication List
10.1016/j.molmet.2025.102119; |
Lundsgaard AM, Del Giudice R, Kanta JM, Larance M, Armour SL, London A, Richter MM, Andersen NR, Nicolaisen TS, Carl CS, Sj, ø, berg KA, Bojsen-M, ø, ller KN, Knudsen JG, Lagerstedt JO, Fritzen AM, Kiens B, Apolipoprotein A-IV is induced by high-fat diets and mediates positive effects on glucose and lipid metabolism. Mol Metab, 95():102119(2025) [pubmed] |
Keyword List
submitter keyword: liver,APOA4 |
Contact List
Mark Larance |
contact affiliation | Charles Perkins Centre, School of Medical Sciences, University of Sydney, Sydney, Australia. |
contact email | mark.larance@sydney.edu.au |
lab head | |
Mark Larance |
contact affiliation | The University of Sydney |
contact email | mark.larance@sydney.edu.au |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD055918 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD055918
- Label: PRIDE project
- Name: Apolipoprotein A-IV is induced by high-fat diets and mediates positive effects on glucose and lipid metabolism